In order to establish long-lasting infections in their mammalian host, filarial nematodes have developed sophisticated strategies to dampen their host's immune response. 
Introduction
It is estimated that worldwide more than 1.5 billion people are at risk of being infected with filarial nematodes. Wuchereria bancrofti, Brugia malayi and Onchocerca volvulus are the causative agents of chronic diseases such as lymphatic filariasis and river blindness [1] and cause a major public health problem. These long-lived parasites have evolved sophisticated strategies to evade the immune response of their host and to survive in the host for more than a decade [2] .
The life cycle of filarial worms in humans and in different animal models is comparable, starting in an arthropod as intermediate host. First stage larvae so called microfilariae (MF) are taken up during a blood meal from a mosquito, blackfly or blood-sucking mite. Within the vector the MF undergo two molts und develop into infective third stage larvae (L3). L3 are transmitted during a second blood meal to their final host. Here, L3 migrate depending on the species to different sides of the body. O. volvulus adults reside in nodules in the subcutaneous tissue while W. bancrofti and B. malayi adults dwell in lymphatic vessels. Different developmental stages have adapted to different niches in the body but utilize similar strategies to promote their survival in their living environment. Chronic helminth infections induce a regulatory network, which is composed of regulatory T cells, alternatively activated macrophages, and anti-inflammatory cytokines [3] . These suppressive cell types might compromise the immune response to the parasite and to unrelated antigens such as vaccines [4] . Impaired proliferation of peripheral T cells to filarial-specific antigens, a phenomenon called lymphocyte hypoproliferation, was already shown in filarial infected humans [5] . Beyond that, pre-existing filarial infection interferes with cellular and humoral immune response to vaccinations such as tetanus toxoid vaccination [6] [7] [8] .
Using the murine model of human filarial infection, Litomosoides sigmodontis, we have shown recently that concurrent nematode infection suppressed the response to model antigen immunizations and to an experimental vaccination against Plasmodium berghei infection in mice [9, 10] . Thereby, L. sigmodontis infection interfered with both, vaccine-induced activation of CD4 + T helper cells and cytotoxic CD8 + T cells in vivo. In general, this helminth-induced immunosuppression depends most likely on the living parasite as drug treatment restored the T cell response [11] . Interaction of helminths with the immune system of their host seems to be mediated by soluble molecules, namely excretory/secretory products (ESP), which are released by live parasites. ESP are biologically active proteins that are either actively exported through secretory pathways or simply leak from the parasite surface [12] . To dissect the composition of ESP, supernatants were collected from in vitro cultured worms and subsequently analyzed by mass spectrometry. Interestingly, a great similarity concerning the protein sequences have been shown for different filarial species such as B. malayi and O. volvulus [13] . Larval stage-specific expression of different proteins was shown for O. volvulus without analyzing the function of these proteins in detail [14, 15] .
The aim of our study was to analyze selected proteins secreted by O. volvulus in order to identify proteins with immunomodulatory capacity. In this context, ESP derived from the parasitic nematode Heligmosomoides polygyrus have been shown to induce Foxp3 + regulatory T cells in vitro and in vivo [16] and recombinant cystatin derived from Acantocheilonema vitae suppressed effector T cell function in vitro [17] and in vivo [18, 19] . Recombinant O. volvulus proteins were generated and tested in an in vitro proliferation assay employing T cell receptor (TCR) transgenic T cells. We identified two ESP from O. volvulus that suppressed proliferation of ovalbumin-specific T cells. OvALT-2 and OvNLT-1 diminished proliferation and cytokine secretion of model antigen-specific T cells in vitro while another recombinant ESP, Ov103, displayed no suppressive capacity. We ruled out contaminating endotoxin or toxic low molecular contaminants as suppressive elements in the recombinant ESP preparations. Furthermore, suppressed proliferation was associated with increased induction of cell death but was resistant to proteinase K treatment. Taken together, we identified two new O. volvulus-derived proteins that suppress the function of model antigen-specific T cells in vitro.
Materials and Methods

Mice
Animal experimentation was conducted at the animal facility of the Bernhard Nocht Institute for Tropical Medicine in agreement with the German animal protection law under the supervision of a veterinarian. The experimental protocols have been reviewed and accepted by the responsible federal health Authorities of the State of Hamburg, Germany, the "Behörde für Gesundheit und Verbraucherschutz" permission number 98/11. Mice were sacrificed by cervical dislocation under CO 2 narcosis. BALB/c mice were purchased from Charles River. OT-II, OT-I and DO11.10 mice were bred in the animal facility of the Bernhard Nocht Institute. Female and male mice were 8-12 weeks of age.
Reagents and antibodies
Anti-CD4-allophycocyanin (clone RM4-5) and Annexin V PE Apoptosis Detection Kit were purchased from eBioscience; CFSE was obtained from Invitrogen (Carlsbad, CA, USA). OVA 323-339 was obtained from JPT Peptide Technologies GmbH (Berlin, Germany) and OVA 257-264 was purchased from MWG Biotech (Ebersberg, Germany).
Preparation of cDNA from adult O. volvulus
Onchocercomas were derived from studies conducted in Liberia and Ghana [20, 21] Primers used for PCR are listed in Table S1 . Following amplification, the PCR products and the expression vector pJC40 [22] were digested using appropriate FastDigest® restriction enzymes (Thermo Scientific) and ligated using T4 DNA ligase (Invitrogen). 5 µl of each ligation were transformed into XL10-gold ultra competent cells according to the supplier's protocol (Stratagene). Positive clones were identified by test digestion and sequencing. After transformation of the respective expression plasmids into E. coli Rossetta gami DE3 cells (OvNLT-1) or E. coli BL21DE3 Star cells (OvALT-2, Ov103, Ov7) (Stratagene), expression of the tagged proteins was initiated by the addition of iso-propyl-beta-Dthiogalactopyranoside (IPTG) (0.05 mM IPTG for OvNLT-1, 0.5 mM IPTG for OvALT-2 and 1 mM IPTG for Ov7) once the cultures had reached A 600 = 0.5 (OvALT-2, Ov7) or A 600 = 0.2(OvNLT-1). Cells were left to grow for additional 3 h (Ov7) or overnight (OvNLT-1, OvALT-2) at 37°C. Expression of Ov103 was carried out by autoinduction [23] . Cells were harvested by centrifugation and the resulting bacterial pellets were resuspended in lysis buffer (50 mM Tris, 500 mM NaCl, 10% glycerol, 0.1% (v/v) Triton X-100, 10 mM imidazole, 1 mM phenylmethylsulfonyl fluoride pH 8.0) for purification of Ov103 and Ov7. For purification of OvNLT-1 and OvALT-2 dithiothreitol (5 mM) was added to the lysis buffer. Pellets were sonicated using a digital sonifier set to 30 watts and 30% amplitude (Branson). The resulting lysate was centrifuged at 10,000 x g for 30 minutes and the supernatant was purified by affinity column chromatography with profinity TM IMAC Ni 2+ -nitrilotriacetic acid resin (Bio-Rad Laboratories, Germany). Columns were washed with 25 column volumes of washing buffer (lysis buffer containing 20 mM imidazole and 5 mM DTT). The recombinant proteins were eluted with lysis buffer containing 300 mM imidazole (OvNLT-1, OvALT-2, Ov7) or 250 mM imidazole (Ov103) and dialysed in 20 mM Tris buffer, pH 7.5, containing 150 mM NaCl, 0.2 mM DTT, prepared with LPS free water (Aqua B. Braun, Melsungen AG, Germany). The purity of the dialysed proteins was controlled by resolution on 12.5% SDS PAGE and Coomassie blue staining. Proteins were concentrated using Millipore 10,000 MWCO (Amicon Ultra) (6000-8000 MWCO for OvALT-2) and the concentration was determined by the method of Bradford [24] . 60 µg/mL of polymyxin B was added to all stages of purification and the purified proteins and contamination with LPS was quantified using LAL Chromogenic Kit (Limulus Amebocyte Lysate; QCL-1000, Lonza, Walkersville, MD, USA). For proteinase K digestion, 0.05 µg proteinase K per µg recombinant protein were added at the beginning and again after 30 min incubation at 56°C. The digestion was stopped after 60 min by incubation at 75°C for 20 min and 95°C for 20 min. To generate a 3 kDa filtrate the recombinant proteins were centrifuged at 4000 x g using Amicon Ultra-4 Centrifugal Filter Units (3 kDa). The resulting filtrate was checked for remaining protein via SDS-PAGE and Coomassie blue-staining.
In vitro stimulation of lymphocytes and analysis of OVA-specific T cell proliferation
Splenocytes (2 x 10 5 / well) were cultivated in 96 well round bottom plates for 72 h at 37°C and 5% CO 2 in RPMI 1640 medium supplemented with 10% fetal calf serum, L-glutamine (2 mg/mL), HEPES (20 mM) and gentamycin (50 µg/mL). For stimulation, cells were either incubated with medium alone or with to 10 ng/mL OVA 323-339 or OVA 257-264 peptide alone or in the presence of ESP (2.5-10 µg/mL), digested ESP or 3 kDa filtrate in triplicates. Apoptosis was measured 6 h after in vitro stimulation of spleen cells in the presence of ESP and the cognate antigen. Concentration of IL-2 and IFN-γ in the supernatant of in vitro stimulated OT-I spleen cells was quantified after 72 h culture employing DuoSet ELISA development system kits (R&D Systems, Wiesbaden, Germany) according to the manufacturer´s instructions. Proliferation after 72 h culture of DO11.10 or OT-II spleen cells was either measured by uptake of 3 H-thymidine for additional 18 h culture or as carboxyfluorescein diacetate succinimidylester (CFSE) dilution as described before [9] . As CFSE dilution is not as sensitive as 3 H-thymidine incorporation we increased the concentration of OVA 323-339 peptide 5-fold in order to measure CFSE dilution in vitro (data not shown). For CFSE labeling 5 x 10 7 spleen cells were resuspended in 10 mL sterile PBS. After addition of 200 µL 50 µM (for in vitro proliferation) or 500 µM (for in vivo proliferation) CFSE cells were incubated for 10 min at 37°C. Labeling reaction was stopped by addition of 40 mL 3% FCS in PBS and cells were washed thrice. For in vitro proliferation CFSE-labeled cells were incubated as described in the previous section. For in vivo proliferation CFSE labeled transgenic OT-II spleen cells (1  x 10 7 ) were injected intravenously into C57BL/6 mice as recipients. The day following transfer mice received 50 µg OVA 332-339 i.p. in PBS. Half of the mice received an additional injection of 20 µg Ov7 i.p. at the day of the adoptive transfer and one day later. Mice were sacrificed 48 h later, spleen cells isolated and stained with anti-CD4 antibody. Number of proliferation cycles was calculated by CFSE dilution.
Flow cytometry
Surface staining of spleen cells was performed using anti-CD4 allophycocyanin antibody as described previously [25] . Cell death was analyzed by 7-AAD incorporation and Annexin V phycoerythrin staining according to the manufacturer´s instructions. Samples were analyzed on a FACS Calibur flow cytometer (Becton Dickinson, Mountain View, CA, USA).
Statistical analysis
Statistical analysis was performed with GraphPad Prism Software (San Diego, USA) using 2-way ANOVA with Bonferroni post-test or students t test. A p-value of < 0.05 was considered to be statistically significant.
Results
Suppression of antigen-specific T cell activation by O. volvulus proteins
To analyze the immunomodulatory capacity of O. volvulusderived ESP we generated a set of different recombinant proteins in E. coli and purified the proteins via their N-terminal histidine tag. In order to control purity of the protein suspensions SDS-PAGE was performed ( Figure 1A ).
Suppressive capacity of the recombinant O. volvulus-derived ESP was analyzed in an in vitro proliferation assay using TCR transgenic mice. In DO11.10 mice all T cells are specific for the OVA 323-339 peptide associated with major histocompatibilty complex II (MHC-II) I-A d [26] . To verify an impact of OvESP on antigen-specific T cell activation DO11.10 spleen cells were stimulated with OVA 323-339 in the presence of increasing concentrations of ESP. Proliferation was quantified as DNA synthesis, i.e.
3 H-incorporation and was suppressed by coincubation with the previously described Ov7 [17] (Figure 1B ). In addition OvALT-2 and OvNLT-1 suppressed proliferation while Ov103 did not modulate OVA-specific proliferation of DO11.10 T cells ( Figure 1C) . To demonstrate suppression of T cells carrying a different transgenic TCR, we analyzed antigenspecific proliferation of splenocytes derived from OT-II mice. These mice were generated on the C57BL/6 background and are transgenic for a MHC class II (I-A b ) restricted OVA 323-339 -specific TCR [26] . Regardless of the genetic background of the T cells, OvALT-2 and OvNLT-1 but not Ov103 suppressed DNA synthesis of OVA-stimulated spleen cells in a dosedependent manner ( Figure 1D ).
As Ov proteins were expressed in E. coli, ESP preparations might be contaminated with low amounts of bacterial pathogenassociated molecular patterns (PAMP) such as lipopolysaccharide (LPS). Although suppressive and nonsuppressive proteins were prepared in parallel we formally wanted to rule out side effects due to endotoxin contamination. Endotoxin activity as measured by Limulus amebocyte lysate assay was maximally 2.4 EU per µg protein and was comparable in suppressive and non-suppressive protein preparations. We added LPS in increasing concentrations to spleen cell cultures derived from DO11.10 mice and measured OVA-specific T cell proliferation. LPS in the range of 0.1 ng/mL to 100 ng/mL corresponding to 1 EU/mL to 1000 EU/mL did not suppress proliferation of T cells while increasing concentrations of Ov7 abolished T cell proliferation in vitro ( Figure 1B) . In addition to the interference of nematode-derived proteins with proliferation of TCR transgenic CD4 + T cells we analyzed the impact on cytokine production by cytotoxic CD8 + T cells. For this purpose, T cells from TCR transgenic OT-I mice that are specific for OVA 257-264 -peptide in association with MHC class I (H-2K b ) were used [27] . Antigen-specific activation of OT-I spleen cells was measured as IL-2 and IFN-γ cytokine secretion. Addition of both, OvALT-2 and OvNLT-1, decreased secretion of IL-2 and IFN-γ compared to addition of Ov103 as negative control protein ( Figure 1E,F) . Taken together, we identified OvALT-2 and OvNLT-1 as ESP that suppress proliferation and cytokine secretion by OVA-specific CD4 + T cells and CD8 + T cells derived from TCR transgenic mice. To directly measure proliferation in addition to DNA synthesis, we labeled OT-II cells with the fluorescent dye CFSE that is diluted upon cell division. After stimulation in the presence of the tested ESP, we gated on CD4 + OT-II T cells and visualized dividing cells by their decreasing CFSE content ( Figure 2AB ). Thereby we calculated the proportion of dividing cells upon antigen-specific stimulation in the presence of Ov7, OvALT-2 and Ov103 as negative control protein ( Figure 2C ). OvALT-2 and Ov7 suppressed the antigen-driven division of OVA-specific OT-II T cells whereas Ov103 again did not affect T cell function.
Limited impact of Ov7 on the clonal expansion of TCR transgenic T cells in vivo
We have shown before that concurrent infection of mice with the filarial nematode L. sigmodontis reduced proliferation of OVA-specific OT-II T cells in vivo [9] . Having identified filaraederived ESP that suppressed OVA-specific T cell proliferation in vitro, we next wanted to address if these ESP would also suppress T cell proliferation in vivo i.e. mimic the suppressive effect of the ongoing filarial infection. Therefore we adoptively transferred OT-II T cells to syngenic C57BL/6 mice that were treated with 20 µg Ov7 or PBS at the day of the adoptive transfer and one day later. OT-II T cells were stimulated in vivo by injection of the cognate antigen OVA 323-339 one day after adoptive transfer and frequencies of OT-II T cells in the spleen were calculated two days later ( Figure 3A) . Ov7 treatment did not reduce the overall proportion of OT-II T cells in the spleen compared to untreated mice ( Figure 3B , p = 0,73). Ov7 treatment slightly interfered with the number of cell divisions undergone by OT-II T cells in vivo ( Figure 3C ). By trend, a reduced number of OT-II T cells divided three times or more in mice that had been treated with Ov7 compared to untreated mice (p= 0,13). As we did not record statistically significant changes in in vivo T cell proliferation by treatment with the welldefined immunosuppressive ESP Ov7 that we employed as a positive control, we did not repeat these experiments with the undefined new ESP.
OvALT-2-and OvNLT-1-mediated inhibition of OVAspecific proliferation is resistant to proteinase K digestion
Working with proteins that have been expressed in bacteria heat-inactivation is a common control to dissect endotoxinmediated from protein-mediated effects. To our surprise, heatinactivation did not abolish the suppressive capacity of the investigated ESP (data not shown and Figure 4C ). This may either suggest that suppression was not caused by the ESP but by other constituents in the recombinant protein preparation, or suppressive ESP may function in a heat-stable manner. In order to rule out that decreased proliferation was mediated by low molecular weight E. coli-derived contaminants we separated ESP using a 3 kDa Amicon filter. Ov7 and OvNLT-1 protein preparations (>3 kDa) reproducibly suppressed proliferation of OVA-specific T cells while Ov103 and the low molecular filtrate of all proteins did not alter proliferation ( Figure  4A ). Thus, we could exclude that toxic low molecular bacterial contaminants in the preparation caused the observed interference with antigen-specific proliferation.
To test if the suppression of OVA-specific proliferation by nematode-derived proteins OvALT-2 and OvNLT-1 was dependent on the intact protein, we treated proteins with proteinase K. Proteinase K activity in the samples was terminated by heat-inactivation after digestion. Complete digestion of the proteins was confirmed by Coomassie-staining after SDS PAGE ( Figure 4B ). Unexpectedly, the digested preparations of OvALT-2 and OvNLT-1 still suppressed the OVA-specific proliferation of DO11.10 T cells to the same extent as the corresponding amount of undigested protein ( Figure 4C ). This T cell suppression by degraded OvALT-2 and OvNLT-1 proteins was not due to cytotoxic products or residual proteinase activity in the reaction as proteinase K treated Ov103 did not suppress DO11.10 T cell proliferation. Therefore, suppression was mediated by heat-stable small fragments of OvNLT-1 and OvALT that were not degraded by proteinase K digestion.
OvALT-2 and OvNLT-1 induce apoptosis in spleen cells
In order to analyze the underlying mechanisms of suppression we measured induction of apoptosis by nematodederived proteins. To distinguish necrosis and apoptosis, spleen cells were stained with 7-aminoactinomycin (7-AAD) and annexin V. One early feature of apoptosis is indicated by the loss of plasma membrane symmetry and exposure of phosphatidylserine at the outer membrane. Annexin V is a phospholipid-binding protein, which binds to phosphatidylserine on the plasma membrane of early apoptotic cells. . The frequency of apoptotic cells was determined after incubation with recombinant proteins or a 3 kDa filtrate of the same protein preparations to rule out effects induced by putative low molecular weight contaminants ( Figure 5A-C) . Neither 3 kDa filtrate (flow through) nor the proteins itself altered the proportion of early apoptotic cells in splenic cultures ( Figure  5D ). In contrast, cells incubated with 5-10 µg/mL OvALT-2 and OvNLT-1 showed a higher proportion of late apoptotic cells after 6 h of incubation ( Figure 5E ). Thereby 10 µg/mL of OvALT-2 and OvNLT-1 induced apoptosis in almost 100% of the spleen cell culture suggesting that the pro-apoptotic activity of ESPs was not cell type specific. Late apoptosis was not detectable in spleen cells cultured in the presence of the 3 kDa filtrate ruling out that toxic low molecular contaminants in OvALT-2 and OvNLT-1 protein preparations induced apoptosis ( Figure 5E ). Ov103 did not induce cell death thus showing specificity of OvALT-2-and OvNLT-1-induced suppression.
Taken together, our results identified OvALT-2 and OvNLT-1 as nematode-derived proteins that mediate suppression of antigen-specific T cell activation. Suppressive capacity of the , or three times and more (M 3 ) after stimulation in the presence of PBS (white bars) or Ov7 (red bars). Shown are combined results from two independent experiments with six mice per group, error bars show SEM. Analysis with students t test revealed no significant statistical difference of the mean (p = 0,73 (B) and p = 0,13 (C, three and more division cycles). This result was reproduced in two other independent experiment using five control and seven Ov7-treated mice. proteins was associated with induction of cell death but was resistant to proteinase K digestion.
Discussion
In our previous studies we demonstrated that concurrent infection with the pathogenic nematodes L. sigmodontis and Strongyloides ratti suppressed the efficiency of vaccinations to bystander antigens in vivo [9, 10, 25] . Particularly infection of mice with L. sigmodontis resulted in drastically reduced antibody titer in response to vaccination with a thymusdependent model antigen. Suppression of B cell response in nematode-infected mice was due to suppression of T helper cell expansion [9] . Moreover, we demonstrated reduced circumsporozoite-specific CD8 + cytotoxic T cell responses upon immunization with a P. berghei-specific vaccine in L. sigmodontis-infected mice compared to non-infected mice [10] . These results are in line with several studies describing the interference of ongoing nematode infections with T cell activation [28] . Screening for nematode products with the potential to suppress T cell activation, several candidates have been described [12, 13] . Cystatins derived from O. volvulus and Acanthocheilonema viteae for instance suppressed proliferation of human peripheral blood lymphocytes in vitro [17] and ameliorated experimental asthma in vivo [18, 19] . In the current study we explored the suppressive capacity of ESP derived from the human pathogen O. volvulus. In addition to the well-described Ov7 we identified two ESP that suppressed T cell function in vitro. OvALT-2 and OvNLT-1 suppressed antigen-specific proliferation of two different MHC-II restricted TCR transgenic T cells, OT-II and DO11.10. Moreover, OvALT-2 and OvNLT-1 suppressed antigen-specific IL-2 and IFN-γ production in spleen cell cultures derived from MHC-I-restricted OT-I mice thus indicating a downregulation of both CD4
+ and CD8 + T cell function. Several in vitro studies using ESP from different helminth species suggest that one evasion strategy represents the induction of cell death in effector cells [29] [30] [31] [32] . Recently, ESP from Fasciola hepatica have been shown to induce apoptosis in eosinophils, a cell type with a central role in the expulsion of helminths [29] . In line with these findings, we demonstrated the induction of cell death in spleen cell cultures upon in vitro exposure to OvALT-2 and OvNLT-1 but not with Ov103.
Working with proteins that are expressed in E. coli, one major concern is a possible contamination with bacterial substances. PAMPs such as LPS might interfere with the activation of OVA-specific T cells. Addition of LPS containing the 10-100 fold endotoxic activity present in our ESP preparations did not modulate T cell proliferation indicating that suppressed proliferation was not due to LPS contamination. To further dissect artificial, E. coli-derived contaminant-mediated effects from protein-mediated suppression we included Ov103. This negative control protein was expressed similarly to the suppressive proteins OvALT-2 and OvNLT-1 and did neither suppress proliferation nor induce cell death in T cells. To exclude suppression mediated by low molecular E. coli-derived toxic contaminants we used Amicon filtration to separate the protein from substances smaller than 3 kDa. Again control protein Ov103 and 3 kDa filtrate of the suppressive proteins OvALT-2 and OvNLT-1 did not change proliferation or induce cell death.
Surprisingly, suppression of OVA-specific T cell proliferation was neither abolished by heat inactivation nor by digestion of the proteins with proteinase K. We controlled complete digestion of the proteins by SDS-PAGE thus ruling out that remaining intact ESP induced observed suppression of proliferation. We excluded interference of the digestion reaction itself with T cell activation, as the digested control protein did not modulate OT-II proliferation. Our results strongly suggest that small peptide fragments derived from OvALT-2 and OvNLT-1 that remained intact after proteinase K digestion and that were not affected by heat-induced disruption of the tertiary structure of the protein would mediate suppression of T cell function. Along this lines suppression of allergic airway inflammation by application of ESP from Heligmosomoides polygyrus during sensitization was not abolished by heat treatment [33] . Moreover, ESP derived from Nippostrongylus brasiliensis inhibited ovalbumin-induced allergy after heat inactivation and proteinase K digestion [34] . As these studies used an undefined ESP concentrate derived from in vitro nematode culture supernatants, the most likely explanation for heat-stable and proteinase-insensitive biologic activity was that immunosuppression was induced by lipids or carbohydrates instead of proteins. Our results, gained with purified recombinant proteins suggest small peptide fragments as additional mediator of proteinase-resistant bioactivity.
However, we cannot formally rule out effects mediated by bacterial-derived toxic proteins in our preparation. It is conceivable that suppressive E. coli-derived non-protein agents might bind selectively to recombinant OvALT-2 and OvNLT-1 but not to Ov103. These contaminants would not be separated by 3 kDa filtration and would be proteinase-resistant. Thus further structural analysis of the recombinant proteins and especially identification of the putative suppressive peptides generated by proteinase K digestion is needed in order to distinguish bacterial-or protein-specific suppression.
Since we observed a strong suppression of the proliferation of TCR transgenic T cells in vitro we asked whether this suppression mimics the inhibitory capacity of nematodes in vivo. In a previous study we showed strong suppression of OVA-specific T cell proliferation after adoptive transfer of OT-II T cells in L. sigmodontis-infected mice [9] . Suppression of OT-II T cell proliferation was less pronounced in mice infected with the intestinal nematode S. ratti [25] . Different parameters such as site and duration of infection most likely contribute to the magnitude of suppression in vivo [35] and might explain the differences in the suppressive capacity of L. sigmodontis and S. ratti. As ESP from O. volvulus strongly suppressed proliferation of OVA-specific T cell in vitro, we tested, whether these proteins are sufficient to suppress proliferation of OT-II T cells in vivo. After injection of 20 µg of onchocystatin, Ov7, we could not significantly dampen the proliferation of OVA-specific T cells in vivo after adoptive transfer into C57BL/6 mice. This may reflect the limited effect of short-term administration of suppressive ESP in comparison to the continuous secretion by the living parasite. As our positive control protein did not cause significant suppression of proliferation in this experimental setup, we did not attempt to test the suppressive capacity of the other ESP in vivo. To this end, firstly more detailed studies are required concerning the establishment of an ESP application route and regimen sufficient to replace the suppressive capacity of concurrent nematode infection.
Taken together, we identified two O. volvulus-derived proteins,
OvALT-2 and OvNLT-1, that act as immunomodulators in vitro and suppress OVA-specific T cell function. Helminths or their secreted products have been shown to protect against autoimmune diseases and allergies in various mouse models [36] . To identify the active compound is a prerequisite to benefit from the therapeutic potential helminths have due to their immunomodulatory capacity. The role of OvALT-2 and OvNLT-1 as potential targets in treating autoimmune diseases need to be further addressed in future studies. Table S1 .
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